Rating History for Viridian Therapeutic (VRDN) by UBS

More Stocks Rated by UBS | Latest Ratings for VRDN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/7/2026 Michael Yee New Coverage Buy
(N/A)		 50.00
(N/A)		 30.20
(28.34)		 -6.16% Details